Applicant, as named in the Orange Book

Teva

Next listed expiry: Azilect on 27 Aug 2027. 3 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Azilect · 2 strengths rasagiline mesylate	rasagiline mesylate	021641	27 Aug 2027	patent
Austedo Xr · 8 strengths deutetrabenazine	deutetrabenazine	216354	10 Jun 2041	patent
Uzedy · 7 strengths risperidone	risperidone	213586	17 Mar 2042	patent, carve-out possible